Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $172.80 | 2 | 62.6% |
| Education | $103.18 | 7 | 37.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novocure Inc. | $143.98 | 1 | $0 (2018) |
| Eisai Inc. | $72.42 | 4 | $0 (2024) |
| Exelixis Inc. | $17.66 | 1 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $16.14 | 1 | $0 (2020) |
| PFIZER INC. | $13.86 | 1 | $0 (2021) |
| Gilead Sciences, Inc. | $11.92 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $72.42 | 4 | Eisai Inc. ($72.42) |
| 2021 | $25.78 | 2 | PFIZER INC. ($13.86) |
| 2020 | $16.14 | 1 | E.R. Squibb & Sons, L.L.C. ($16.14) |
| 2019 | $17.66 | 1 | Exelixis Inc. ($17.66) |
| 2018 | $143.98 | 1 | Novocure Inc. ($143.98) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $28.82 | General |
| Category: Oncology | ||||||
| 09/20/2024 | Eisai Inc. | Lenvima (Drug) | Education | Cash or cash equivalent | $13.35 | General |
| Category: Oncology | ||||||
| 08/26/2024 | Eisai Inc. | Lenvima (Drug) | Education | Cash or cash equivalent | $13.35 | General |
| Category: Oncology | ||||||
| 03/13/2024 | Eisai Inc. | Lenvima (Drug) | Education | Cash or cash equivalent | $16.90 | General |
| Category: Oncology | ||||||
| 07/20/2021 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $13.86 | General |
| Category: ONCOLOGY | ||||||
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 07/21/2020 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Education | Cash or cash equivalent | $16.14 | General |
| Category: Oncology | ||||||
| 05/02/2019 | Exelixis Inc. | Cabometyx (Drug) | Education | In-kind items and services | $17.66 | General |
| Category: Oncology | ||||||
| 02/08/2018 | Novocure Inc. | Oncology (Device) | Food and Beverage | Cash or cash equivalent | $143.98 | General |
| Category: Optune | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 452 | 916 | $187,589 | $85,159 |
| 2022 | 5 | 476 | 819 | $161,816 | $73,765 |
| 2021 | 5 | 362 | 622 | $123,819 | $59,409 |
| 2020 | 7 | 416 | 670 | $133,481 | $54,251 |
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 285 | 686 | $128,282 | $61,239 | 47.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 63 | 68 | $24,412 | $9,208 | 37.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 35 | 86 | $18,404 | $8,057 | 43.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 35 | 35 | $10,185 | $4,310 | 42.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 14 | 20 | $3,660 | $1,245 | 34.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 20 | 21 | $2,646 | $1,100 | 41.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 287 | 601 | $112,387 | $53,139 | 47.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 62 | 62 | $18,042 | $7,391 | 41.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 61 | 69 | $16,905 | $7,309 | 43.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 24 | 40 | $8,560 | $3,233 | 37.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 42 | 47 | $5,922 | $2,693 | 45.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 234 | 453 | $84,711 | $43,058 | 50.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 49 | 58 | $14,210 | $6,178 | 43.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 40 | 40 | $11,640 | $5,114 | 43.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 19 | 49 | $10,486 | $4,028 | 38.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 20 | 22 | $2,772 | $1,031 | 37.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 175 | 391 | $73,117 | $29,185 | 39.9% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 76 | 76 | $22,116 | $9,259 | 41.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 60 | 70 | $17,150 | $7,488 | 43.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 33 | 53 | $10,922 | $4,276 | 39.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 38 | 44 | $5,544 | $2,496 | 45.0% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 22 | 24 | $1,824 | $848.98 | 46.5% |
| 38222 | Bone marrow biopsy and aspiration | Facility | 2020 | 12 | 12 | $2,808 | $699.10 | 24.9% |
About Dr. Katherine Exten, M.D
Dr. Katherine Exten, M.D is a Internal Medicine healthcare provider based in Mansfield, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2011. The National Provider Identifier (NPI) number assigned to this provider is 1982996237.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Katherine Exten, M.D has received a total of $275.98 in payments from pharmaceutical and medical device companies, with $72.42 received in 2024. These payments were reported across 9 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($172.80).
As a Medicare-enrolled provider, Exten has provided services to 1,706 Medicare beneficiaries, totaling 3,027 services with total Medicare billing of $272,584. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Student in an Organized Health Care Education/Training Program, Hematology & Oncology
- Location Mansfield, OH
- Active Since 05/04/2011
- Last Updated 01/25/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1982996237
Products in Payments
- Oncology (Device) $143.98
- Lenvima (Drug) $72.42
- Cabometyx (Drug) $17.66
- OPDIVO (Biological) $16.14
- XTANDI (Drug) $13.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Mansfield
David Subich, Md, MD
Internal Medicine — Payments: $35,724
Yohannes Bayissa, M.d, M.D
Internal Medicine — Payments: $32,782
Mitchell Stelzer, Do, DO
Internal Medicine — Payments: $27,982
Dr. Robert Barkett, Md, MD
Internal Medicine — Payments: $19,898
Dr. Phillip Saunders, D.o, D.O
Internal Medicine — Payments: $19,674
Dr. Lindsey Vandyke, D.o, D.O
Internal Medicine — Payments: $18,200